ID | Term | Allele | Alleles | Background | Color Key |
---|
MP:0002023 | B cell derived lymphoma |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac * C57BL/6J | color key |
MP:0004939 | abnormal B cell morphology |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac * C57BL/6J | color key |
MP:0000003 | abnormal adipose tissue morphology |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac * C57BL/6J | color key |
MP:0000662 | abnormal branching of the mammary ductal tree |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac | color key |
MP:0009116 | abnormal brown fat cell morphology |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac * C57BL/6J | color key |
MP:0005076 | abnormal cell differentiation |
Ncoa3tm1.1Bwo |
Ncoa3tm1.1Bwo/Ncoa3tm1.1Bwo | involves: 129S/SvEv * C57BL/6J | color key |
MP:0005076 | abnormal cell differentiation |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac * C57BL/6J | color key |
MP:0003091 | abnormal cell migration |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac | color key |
MP:0005621 | abnormal cell physiology |
Ncoa3tm1Rsd |
Ncoa3tm1Rsd/Ncoa3tm1Rsd | involves: 129S1/Sv * 129X1/SvJ * C57BL/6 | color key |
MP:0003866 | abnormal defecation |
Ncoa3tm1.1Bwo |
Ncoa3tm1.1Bwo/Ncoa3tm1.1Bwo | involves: 129S/SvEv * C57BL/6J | color key |
MP:0006319 | abnormal epididymal fat pad morphology |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac * C57BL/6J | color key |
MP:0002332 | abnormal exercise endurance |
Ncoa3tm1.1Bwo |
Ncoa3tm1.1Bwo/Ncoa3tm1.1Bwo | involves: 129S/SvEv * C57BL/6J | color key |
MP:0002332 | abnormal exercise endurance |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac * C57BL/6J | color key |
MP:0003699 | abnormal female reproductive system physiology |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac | color key |
MP:0002078 | abnormal glucose homeostasis |
Ncoa3tm1.1Bwo |
Ncoa3tm1.1Bwo/Ncoa3tm1.1Bwo | involves: 129S/SvEv * C57BL/6J | color key |
MP:0003953 | abnormal hormone level |
Ncoa3tm1.1Bwo |
Ncoa3tm1.1Bwo/Ncoa3tm1.1Bwo | involves: 129S/SvEv * C57BL/6J | color key |
MP:0002401 | abnormal lymphopoiesis |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac * C57BL/6J | color key |
MP:0000628 | abnormal mammary gland development |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac | color key |
MP:0006035 | abnormal mitochondrion morphology |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac * C57BL/6J | color key |
MP:0003084 | abnormal skeletal muscle fiber morphology |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac * C57BL/6J | color key |
MP:0002356 | abnormal spleen red pulp morphology |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac * C57BL/6J | color key |
MP:0001140 | abnormal vagina epithelium morphology |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac | color key |
MP:0005150 | cachexia |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac | color key |
MP:0004893 | decreased adiponectin level |
Ncoa3tm1.1Bwo |
Ncoa3tm1.1Bwo/Ncoa3tm1.1Bwo | involves: 129S/SvEv * C57BL/6J | color key |
MP:0001265 | decreased body size |
Ncoa3tm1Rsd |
Ncoa3tm1Rsd/Ncoa3tm1Rsd | involves: 129S1/Sv * 129X1/SvJ * C57BL/6 | color key |
MP:0005534 | decreased body temperature |
Ncoa3tm1.1Bwo |
Ncoa3tm1.1Bwo/Ncoa3tm1.1Bwo | involves: 129S/SvEv * C57BL/6J | color key |
MP:0001262 | decreased body weight |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac | color key |
MP:0001262 | decreased body weight |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac * C57BL/6J | color key |
MP:0001262 | decreased body weight |
Ncoa3tm1Rsd |
Ncoa3tm1Rsd/Ncoa3tm1Rsd | involves: 129S1/Sv * 129X1/SvJ * C57BL/6 | color key |
MP:0001262 | decreased body weight |
Ncoa3tm2.2Jxu |
Ncoa3tm2.2Jxu/Ncoa3tm2.2Jxu | involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6 * FVB/N | color key |
MP:0001780 | decreased brown adipose tissue amount |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac * C57BL/6J | color key |
MP:0009125 | decreased brown fat cell lipid droplet size |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac * C57BL/6J | color key |
MP:0009136 | decreased brown fat cell size |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac * C57BL/6J | color key |
MP:0008964 | decreased carbon dioxide production |
Ncoa3tm1.1Bwo |
Ncoa3tm1.1Bwo/Ncoa3tm1.1Bwo | involves: 129S/SvEv * C57BL/6J | color key |
MP:0000352 | decreased cell proliferation |
Ncoa3tm1Rsd |
Ncoa3tm1Rsd/Ncoa3tm1Rsd | involves: 129S1/Sv * 129X1/SvJ * C57BL/6 | color key |
MP:0000186 | decreased circulating HDL cholesterol level |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac * C57BL/6J | color key |
MP:0005179 | decreased circulating cholesterol level |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac * C57BL/6J | color key |
MP:0005181 | decreased circulating estradiol level |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac | color key |
MP:0002702 | decreased circulating free fatty acid level |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac * C57BL/6J | color key |
MP:0002696 | decreased circulating glucagon level |
Ncoa3tm1.1Bwo |
Ncoa3tm1.1Bwo/Ncoa3tm1.1Bwo | involves: 129S/SvEv * C57BL/6J | color key |
MP:0005560 | decreased circulating glucose level |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac * C57BL/6 | color key |
MP:0005560 | decreased circulating glucose level |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac * C57BL/6J | color key |
MP:0002727 | decreased circulating insulin level |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac * C57BL/6J | color key |
MP:0004701 | decreased circulating insulin-like growth factor I level |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac | color key |
MP:0004701 | decreased circulating insulin-like growth factor I level |
Ncoa3tm1Rsd |
Ncoa3tm1Rsd/Ncoa3tm1Rsd | involves: 129S1/Sv * 129X1/SvJ * C57BL/6 | color key |
MP:0004701 | decreased circulating insulin-like growth factor I level |
Ncoa3tm2.2Jxu |
Ncoa3tm2.2Jxu/Ncoa3tm2.2Jxu | involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6 * FVB/N | color key |
MP:0002644 | decreased circulating triglyceride level |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac * C57BL/6J | color key |
MP:0003910 | decreased eating behavior |
Ncoa3tm1.1Bwo |
Ncoa3tm1.1Bwo/Ncoa3tm1.1Bwo | involves: 129S/SvEv * C57BL/6J | color key |
MP:0001698 | decreased embryo size |
Ncoa3tm1Rsd |
Ncoa3tm1Rsd/Ncoa3tm1Rsd | involves: 129S1/Sv * 129X1/SvJ * C57BL/6 | color key |
MP:0009289 | decreased epididymal fat pad weight |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac * C57BL/6J | color key |
MP:0008658 | decreased interleukin-1 beta secretion |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac * C57BL/6 | color key |
MP:0001935 | decreased litter size |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac | color key |
MP:0003402 | decreased liver weight |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac * C57BL/6J | color key |
MP:0003355 | decreased ovulation rate |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac | color key |
MP:0005290 | decreased oxygen consumption |
Ncoa3tm1.1Bwo |
Ncoa3tm1.1Bwo/Ncoa3tm1.1Bwo | involves: 129S/SvEv * C57BL/6J | color key |
MP:0003179 | decreased platelet cell number |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac * C57BL/6J | color key |
MP:0009341 | decreased splenocyte apoptosis |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac * C57BL/6J | color key |
MP:0005659 | decreased susceptibility to diet-induced obesity |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac * C57BL/6J | color key |
MP:0002310 | decreased susceptibility to hepatic steatosis |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac * C57BL/6J | color key |
MP:0010025 | decreased total body fat amount |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac * C57BL/6J | color key |
MP:0001783 | decreased white adipose tissue amount |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac * C57BL/6J | color key |
MP:0009133 | decreased white fat cell size |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac * C57BL/6J | color key |
MP:0001938 | delayed sexual maturation |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac | color key |
MP:0002636 | delayed vaginal opening |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac | color key |
MP:0002427 | disproportionate dwarf |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac | color key |
MP:0000691 | enlarged spleen |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac * C57BL/6J | color key |
MP:0001559 | hyperglycemia |
Ncoa3tm1.1Bwo |
Ncoa3tm1.1Bwo/Ncoa3tm1.1Bwo | involves: 129S/SvEv * C57BL/6J | color key |
MP:0001402 | hypoactivity |
Ncoa3tm1.1Bwo |
Ncoa3tm1.1Bwo/Ncoa3tm1.1Bwo | involves: 129S/SvEv * C57BL/6J | color key |
MP:0011049 | impaired adaptive thermogenesis |
Ncoa3tm1.1Bwo |
Ncoa3tm1.1Bwo/Ncoa3tm1.1Bwo | involves: 129S/SvEv * C57BL/6J | color key |
MP:0011049 | impaired adaptive thermogenesis |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac * C57BL/6 | color key |
MP:0005293 | impaired glucose tolerance |
Ncoa3tm1.1Bwo |
Ncoa3tm1.1Bwo/Ncoa3tm1.1Bwo | involves: 129S/SvEv * C57BL/6J | color key |
MP:0005292 | improved glucose tolerance |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac * C57BL/6J | color key |
MP:0005014 | increased B cell number |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac * C57BL/6J | color key |
MP:0005154 | increased B cell proliferation |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac * C57BL/6J | color key |
MP:0008074 | increased CD4-positive T cell number |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac * C57BL/6J | color key |
MP:0008078 | increased CD8-positive T cell number |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac * C57BL/6J | color key |
MP:0005348 | increased T cell proliferation |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac * C57BL/6J | color key |
MP:0001260 | increased body weight |
Ncoa3tm1.1Bwo |
Ncoa3tm1.1Bwo/Ncoa3tm1.1Bwo | involves: 129S/SvEv * C57BL/6J | color key |
MP:0008963 | increased carbon dioxide production |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac * C57BL/6J | color key |
MP:0004702 | increased circulating insulin-like growth factor I level |
Ncoa3tm1.1Bwo |
Ncoa3tm1.1Bwo/Ncoa3tm1.1Bwo | involves: 129S/SvEv * C57BL/6J | color key |
MP:0008641 | increased circulating interleukin-1 beta level |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac * C57BL/6 | color key |
MP:0008596 | increased circulating interleukin-6 level |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac * C57BL/6 | color key |
MP:0005669 | increased circulating leptin level |
Ncoa3tm1.1Bwo |
Ncoa3tm1.1Bwo/Ncoa3tm1.1Bwo | involves: 129S/SvEv * C57BL/6J | color key |
MP:0008553 | increased circulating tumor necrosis factor level |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac * C57BL/6 | color key |
MP:0004889 | increased energy expenditure |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac * C57BL/6J | color key |
MP:0006094 | increased fat cell size |
Ncoa3tm1.1Bwo |
Ncoa3tm1.1Bwo/Ncoa3tm1.1Bwo | involves: 129S/SvEv * C57BL/6J | color key |
MP:0005440 | increased glycogen level |
Ncoa3tm1.1Bwo |
Ncoa3tm1.1Bwo/Ncoa3tm1.1Bwo | involves: 129S/SvEv * C57BL/6J | color key |
MP:0004499 | increased incidence of chemically-induced tumors |
Ncoa3tm1.1Bwo |
Ncoa3tm1.1Bwo/Ncoa3tm1.1Bwo | involves: 129S/SvEv * C57BL/6J | color key |
MP:0002891 | increased insulin sensitivity |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac * C57BL/6J | color key |
MP:0008705 | increased interleukin-6 secretion |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac * C57BL/6 | color key |
MP:0000218 | increased leukocyte cell number |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac * C57BL/6J | color key |
MP:0009355 | increased liver triglyceride level |
Ncoa3tm1.1Bwo |
Ncoa3tm1.1Bwo/Ncoa3tm1.1Bwo | involves: 129S/SvEv * C57BL/6J | color key |
MP:0005013 | increased lymphocyte cell number |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac * C57BL/6J | color key |
MP:0002022 | increased lymphoma incidence |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac * C57BL/6J | color key |
MP:0005289 | increased oxygen consumption |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac * C57BL/6J | color key |
MP:0010378 | increased respiratory quotient |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac * C57BL/6J | color key |
MP:0008483 | increased spleen germinal center size |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac * C57BL/6J | color key |
MP:0009788 | increased susceptibility to bacterial infection induced morbidity/mortality |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac * C57BL/6 | color key |
MP:0008735 | increased susceptibility to endotoxin shock |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac * C57BL/6 | color key |
MP:0010024 | increased total body fat amount |
Ncoa3tm1.1Bwo |
Ncoa3tm1.1Bwo/Ncoa3tm1.1Bwo | involves: 129S/SvEv * C57BL/6J | color key |
MP:0008560 | increased tumor necrosis factor secretion |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac * C57BL/6 | color key |
MP:0005331 | insulin resistance |
Ncoa3tm1.1Bwo |
Ncoa3tm1.1Bwo/Ncoa3tm1.1Bwo | involves: 129S/SvEv * C57BL/6J | color key |
MP:0000024 | lowered ear position |
Ncoa3tm1Rsd |
Ncoa3tm1Rsd/Ncoa3tm1Rsd | involves: 129S1/Sv * 129X1/SvJ * C57BL/6 | color key |
MP:0002169 | no abnormal phenotype detected |
Ncoa3tm2.1Jxu |
Ncoa3tm2.1Jxu/Ncoa3tm2.1Jxu | involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6 | color key |
MP:0003620 | oliguria |
Ncoa3tm1.1Bwo |
Ncoa3tm1.1Bwo/Ncoa3tm1.1Bwo | involves: 129S/SvEv * C57BL/6J | color key |
MP:0011110 | partial preweaning lethality |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac | color key |
MP:0001732 | postnatal growth retardation |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac | color key |
MP:0002083 | premature death |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac * C57BL/6J | color key |
MP:0009006 | prolonged estrous cycle |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac | color key |
MP:0010179 | rough coat |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac | color key |
MP:0000601 | small liver |
Ncoa3tm1Jxu |
Ncoa3tm1Jxu/Ncoa3tm1Jxu | involves: 129S6/SvEvTac * C57BL/6J | color key |